IL129957A - Substituted phenols and phenyl esters and pharmaceutical compositions containing them - Google Patents

Substituted phenols and phenyl esters and pharmaceutical compositions containing them

Info

Publication number
IL129957A
IL129957A IL12995797A IL12995797A IL129957A IL 129957 A IL129957 A IL 129957A IL 12995797 A IL12995797 A IL 12995797A IL 12995797 A IL12995797 A IL 12995797A IL 129957 A IL129957 A IL 129957A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
substituted phenols
phenyl esters
esters
Prior art date
Application number
IL12995797A
Other languages
English (en)
Other versions
IL129957A0 (en
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of IL129957A0 publication Critical patent/IL129957A0/xx
Publication of IL129957A publication Critical patent/IL129957A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/18—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
    • C07C39/19—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
IL12995797A 1996-11-20 1997-10-07 Substituted phenols and phenyl esters and pharmaceutical compositions containing them IL129957A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75552896A 1996-11-20 1996-11-20
PCT/US1997/018055 WO1998022418A1 (en) 1996-11-20 1997-10-07 Substituted phenols and thiophenols useful as antioxidant agents

Publications (2)

Publication Number Publication Date
IL129957A0 IL129957A0 (en) 2000-02-29
IL129957A true IL129957A (en) 2005-06-19

Family

ID=25039544

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12995797A IL129957A (en) 1996-11-20 1997-10-07 Substituted phenols and phenyl esters and pharmaceutical compositions containing them

Country Status (22)

Country Link
EP (1) EP0942896B1 (xx)
JP (2) JP4267705B2 (xx)
KR (2) KR100698995B1 (xx)
CN (1) CN1168693C (xx)
AR (1) AR009429A1 (xx)
AT (1) ATE237574T1 (xx)
AU (1) AU734050B2 (xx)
BR (1) BR9713372A (xx)
CA (1) CA2271054C (xx)
DE (1) DE69721040T2 (xx)
DK (1) DK0942896T3 (xx)
ES (1) ES2191828T3 (xx)
HK (1) HK1021970A1 (xx)
HU (1) HUP9904244A3 (xx)
IL (1) IL129957A (xx)
NO (1) NO318039B1 (xx)
NZ (1) NZ335440A (xx)
PT (1) PT942896E (xx)
SI (1) SI0942896T1 (xx)
TW (1) TW508349B (xx)
WO (1) WO1998022418A1 (xx)
ZA (1) ZA9710315B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1695959A1 (en) * 1997-05-14 2006-08-30 Atherogenics, Inc. Compouds and methods for the inhibition of the expression of VCAM-1
US6852878B2 (en) 1998-05-14 2005-02-08 Atherogenics, Inc. Thioketals and thioethers for inhibiting the expression of VCAM-1
ES2283933T3 (es) * 1997-05-14 2007-11-01 Atherogenics, Inc. Ester del acido succinico de probucol para la inhibicion de la expresion de vcam-1.
US6670398B2 (en) 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
US6020383A (en) * 1999-01-11 2000-02-01 Eastman Chemicals Company Method for reducing blood cholesterol and/or blood triglycerides
IL161522A0 (en) * 2001-10-25 2004-09-27 Atherogenics Inc Compounds and methods for treating transplant rejection
WO2005102323A2 (en) 2004-04-20 2005-11-03 Atherogenics, Inc. Process of preparing esters and ethers of probucol and derivatives thereof
KR100725582B1 (ko) 2004-06-29 2007-06-08 주식회사 동부하이텍 식물병원균의 생장억제활성을 갖는 알킬페놀 유도체
JP5191739B2 (ja) * 2004-12-22 2013-05-08 チバ ホールディング インコーポレーテッド 抗ラジカル剤
CN101686676A (zh) 2007-03-26 2010-03-31 沙路特里亚制药有限责任公司 用于治疗糖尿病的方法和普罗布考衍生物的组合物
KR101420083B1 (ko) * 2012-04-04 2014-07-15 이화여자대학교 산학협력단 Ｕｃｈ－ｌ１ 저해 화합물 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 ｕｃｈ－ｌ１ 관련 질환의 예방 또는 치료용 약학적 조성물
WO2014185561A1 (ko) * 2013-05-13 2014-11-20 이화여자대학교 산학협력단 신규한 화합물 또는 이의 약학적으로 허용 가능한 염 및 이를 유효성분으로 함유하는 ｕｃｈ－ｌ１ 관련 질환의 예방 또는 치료용 약학적 조성물
WO2016170704A1 (ja) * 2015-04-23 2016-10-27 株式会社日本ハイポックス 慢性呼吸器疾患治療剤及び心臓の線維化抑制組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57176038A (en) * 1981-04-21 1982-10-29 Fuji Photo Film Co Ltd Silver halide color photographic material
CA2050514A1 (en) * 1990-09-14 1992-03-15 Bradley C. Pearce Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
DE4109627A1 (de) * 1991-03-23 1992-09-24 Boehringer Mannheim Gmbh Neue phenolether, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
CA2096496A1 (en) * 1992-05-29 1993-11-30 Bradley C. Pearce Acyclic tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia
DE69217221T2 (de) * 1992-09-18 1997-05-15 Nippon Hypox Lab Inc Hydrochinonderivate und diese enthaltende Antioxydantien sowie Tumorinhibitoren
TW393475B (en) * 1992-10-16 2000-06-11 Chugai Pharmaceutical Co Ltd 4-alkoxyl-2,6-di-t-butyl phenol derivatives
JP3050733B2 (ja) * 1992-10-16 2000-06-12 中外製薬株式会社 ４−アルコキシ−２，６−ジ−ｔ−ブチルフェノール誘導体

Also Published As

Publication number Publication date
DE69721040D1 (de) 2003-05-22
HUP9904244A3 (en) 2002-07-29
AR009429A1 (es) 2000-04-12
ATE237574T1 (de) 2003-05-15
JP2009132710A (ja) 2009-06-18
CA2271054C (en) 2005-12-13
KR100698995B1 (ko) 2007-03-26
HK1021970A1 (en) 2000-07-21
KR100648118B1 (ko) 2006-11-28
JP4267705B2 (ja) 2009-05-27
WO1998022418A1 (en) 1998-05-28
ES2191828T3 (es) 2003-09-16
EP0942896A1 (en) 1999-09-22
NO992390D0 (no) 1999-05-19
HUP9904244A2 (hu) 2000-09-28
JP2001504483A (ja) 2001-04-03
DK0942896T3 (da) 2003-07-28
CN1237955A (zh) 1999-12-08
ZA9710315B (en) 1998-05-20
TW508349B (en) 2002-11-01
CN1168693C (zh) 2004-09-29
DE69721040T2 (de) 2003-10-16
AU4809897A (en) 1998-06-10
NO318039B1 (no) 2005-01-24
AU734050B2 (en) 2001-05-31
SI0942896T1 (en) 2003-08-31
NZ335440A (en) 2001-07-27
EP0942896B1 (en) 2003-04-16
KR20060016839A (ko) 2006-02-22
IL129957A0 (en) 2000-02-29
CA2271054A1 (en) 1998-05-28
NO992390L (no) 1999-07-16
PT942896E (pt) 2003-07-31
BR9713372A (pt) 2000-03-21
KR20000057135A (ko) 2000-09-15

Similar Documents

Publication Publication Date Title
IL121236A0 (en) Cycloalkano-pyridines their preparation and pharmaceutical compositions containing them
IL122447A0 (en) Pharmaceutical composition with anaestheric effect
IL114622A0 (en) Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
EG24118A (en) Pharmaceutical compositions
GB9615089D0 (en) Esters and compositions comprising them
HUP0000733A3 (en) Aminoguanidines and alkoxyguanidines as and pharmaceutical compositions containing them
EP0943327A4 (en) DRUG
HUP0001309A3 (en) 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them
HUP9901452A3 (en) Bicyclic-aromatic compounds and pharmaceutical compositions containing them
IL128058A0 (en) Illudin analogs and pharmaceutical compositions containing the same
GB9616672D0 (en) Pharmaceutical compositions
ZA9710006B (en) Novel pharmaceutical compositions
IL129957A (en) Substituted phenols and phenyl esters and pharmaceutical compositions containing them
PL331423A1 (en) Muporocin and chlorohexidrin containing compositions
GB9610359D0 (en) Pharmaceutical compositions
IL125998A0 (en) Taxoids preparation thereof and pharmaceutical compositions containing them
HUP0000460A3 (en) Imidazopyridazines and pharmaceutical compositions thereof
ZA979726B (en) Pharmaceutical compositions
GB9606429D0 (en) Pharmaceutical compositions
GB9613457D0 (en) Pharmaceutical compositions
SG87031A1 (en) Cynanate ester composition and cured product thereof
GB9623962D0 (en) Pharmaceutical composition
GB9618376D0 (en) Pharmaceutical compositions
GB9610136D0 (en) Pharmaceutical compositions
IL155070A0 (en) Novel phenyl esters

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees